Journal article
Inhibition of group 1 p21-activated kinases suppresses pancreatic stellate cell activation and increases survival of mice with pancreatic cancer
D Yeo, P Phillips, GS Baldwin, H He, M Nikfarjam
International Journal of Cancer | WILEY | Published : 2017
DOI: 10.1002/ijc.30615
Abstract
Pancreatic cancer remains one of the most lethal of all solid tumors. Pancreatic stellate cells (PSCs) are primarily responsible for the fibrosis that constitutes the stroma and p21-activated kinase 1 (PAK1) may have a role in signalling pathways involving PSCs. This study aimed to examine the role of PAK1 in PSCs and in the interaction of PSCs with pancreatic cancer cells. Human PSCs were isolated using the modified outgrowth method. The effect of inhibiting PAK1 with group 1 PAK inhibitor, FRAX597, on cell proliferation and apoptosis in vitro was measured by thymidine incorporation and annexin V assays, respectively. The effect of depleting host PAK1 on the survival of mice with pancreatic..
View full abstractGrants
Awarded by Pancare Foundation
Funding Acknowledgements
This work was supported by grants from the National Health and Medical Research Council of Australia (1020983, GSB), the Pancare Foundation (GSB, MN), the Austin Hospital Medical Research Foundation (MN), and the Sir Edward Dunlop Foundation (MN). PP is supported by a National Health and Medical Research Council (NHMRC) CDF1 Fellowship. DY is supported by Australian Rotary Health (The Ian Loxton Pancreatic Cancer Research PhD Scholarship).